VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 51 filers reported holding VOYAGER THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $20,328 | -32.3% | 2,623 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $30,033 | +200.3% | 2,623 | +29.8% | 0.00% | – |
Q1 2021 | $10,000 | -28.6% | 2,021 | 0.0% | 0.00% | -100.0% |
Q4 2020 | $14,000 | -36.4% | 2,021 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $22,000 | -15.4% | 2,021 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $26,000 | +44.4% | 2,021 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $18,000 | -35.7% | 2,021 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $28,000 | -20.0% | 2,021 | 0.0% | 0.00% | -50.0% |
Q3 2019 | $35,000 | -25.5% | 2,021 | +17.4% | 0.00% | 0.0% |
Q2 2019 | $47,000 | +42.4% | 1,721 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $33,000 | +106.2% | 1,721 | 0.0% | 0.00% | +100.0% |
Q4 2018 | $16,000 | -51.5% | 1,721 | 0.0% | 0.00% | -50.0% |
Q3 2018 | $33,000 | -2.9% | 1,721 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $34,000 | +47.8% | 1,721 | +38.8% | 0.00% | +100.0% |
Q1 2018 | $23,000 | +9.5% | 1,240 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $21,000 | +320.0% | 1,240 | +138.0% | 0.00% | – |
Q3 2017 | $5,000 | 0.0% | 521 | 0.0% | 0.00% | – |
Q2 2017 | $5,000 | -28.6% | 521 | 0.0% | 0.00% | – |
Q1 2017 | $7,000 | – | 521 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 6,391,176 | $60,077,000 | 50.34% |
ARMISTICE CAPITAL, LLC | 2,836,000 | $26,658,000 | 2.02% |
Casdin Capital, LLC | 1,128,075 | $10,604,000 | 1.81% |
BB BIOTECH AG | 2,865,841 | $26,939,000 | 0.86% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,284,697 | $12,076,000 | 0.81% |
Aevitas Wealth Management, Inc. | 48,300 | $454,000 | 0.46% |
GREAT POINT PARTNERS LLC | 365,132 | $3,432,000 | 0.43% |
Patriot Financial Group Insurance Agency, LLC | 61,320 | $576,000 | 0.38% |
HARBOURVEST PARTNERS LLC | 72,726 | $684,000 | 0.32% |
Birchview Capital, LP | 33,000 | $310,000 | 0.29% |